
VirexaTradex claims to be authorized by the Cyprus Securities and Exchange Commission(CySEC) and the Seychelles Financial Services Authority (FSA). However, our search of the official CySEC and Seychelles FSA licensee register found no record of it or the stated licence. This discrepancy strongly suggests that the firm’s regulatory claims are inaccurate or deliberately misleading.
Besides, VirexaTradex does not provide any other licensing information. Until verifiable evidence of legitimate authorization is provided, we assess VirexaTradex as a likely unlicensed or fraudulent broker and advise extreme caution.



On Jul 21, 2026, the Financial Conduct Authority (FCA) issued a warning against VirexaTradex, believing this company might be providing financial services or products without proper authorization in the UK. You may visit: https://www.fca.org.uk/news/warnings/virexa-tradex

On Jul 21, 2026, the Financial Conduct Authority (FCA) issued a warning against VirexaTradex, believing this company might be providing financial services or products without proper authorization in the UK. You may visit: https://www.fca.org.uk/news/warnings/virexa-tradex
